Vertex Portfolio News

Here are the latest updates on our portfolio companies across the Vertex network. Stay connected by signing up for our monthly newsletter here.

- BigEndian Semiconductors (SE Asia & India) signed an agreement with India’s TDB-DST for ₹130 crore of research and development support.

• Bites (Israel) raised a US$40 million Series A to bring AI training to frontline workers.
• Classiq (Israel) agreed to be acquired by Intel in a deal reported at US$2.3 billion.
• Drylab (SE Asia & India) raised a US$3 million seed round led by Vertex Ventures SE Asia & India to build AI scientists.
• Matchpoint Therapeutics (HC) raised a US$150 million Series B to advance its pipeline of oral autoimmune drugs.
• Metaview (US) raised a US$60 million Series C to expand its agentic recruiting platform.
• Neolix (Growth) secured US$400 million in new financing for its autonomous delivery vehicles.
• RapidCanvas (SE Asia & India) raised a US$29 million Series B led by Vertex Ventures SE Asia & India.

- Databricks (China) partnered with Pricefx to bring AI-powered pricing intelligence to the Databricks Data + AI Platform.

• Human Security (US) saw OpenX become the first platform to adopt its ad verification suite.
• Nium (SE Asia & India, Growth) handled US$500 million in cross-border payments in the first year of its partnership with Relay.
• Nium (SE Asia & India, Growth) partnered with BNK Busan Bank to strengthen cross-border payments and digital banking.
• Nium (SE Asia & India, Growth) will power RedotPay’s off-ramp expansion.
• Quollio (Japan) was adopted by Seiko Epson to build a semantic data foundation for AI use.
• RedotPay (China) partnered with Nium on stablecoin off-ramp payouts.
• Spyne (SE Asia & India) announced a data integration with Cox Automotive’s Dealertrack DMS for its dealer customers.

- Axonius (Israel) launched AI Workforce, a set of virtual workers that monitor and fix risks for security teams.

• Harbour BioMed (China) reported sustained asthma control with twice-yearly dosing potential for HBM9378.
• Harbour BioMed (China) received China NMPA approval for batoclimab to treat generalized myasthenia gravis.
• Kapiva (SE Asia & India, Growth) crossed ₹460 crore in FY26 revenue and targets EBITDA profitability by Q4 FY27.
• Kuku (SE Asia & India, Growth) turned profitable in FY26 as revenue grew six-fold to ₹1,484 crore.
• PatSnap (Growth) launched AI agents that extract SAR data and identify lead compounds from small molecule patents.
• RapidCanvas (SE Asia & India) acquired Entytle to bring AI execution to the industrial aftermarket.
• Tulip (US) launched a Validation Accelerator for GxP life sciences manufacturers.

- Cymulate (Israel, Growth) received Frost & Sullivan’s 2026 Indian Competitive Strategy Leadership Recognition.

• Palmonas (SE Asia & India) ranked #10 on LinkedIn’s Top Startups 2026 India list.
• Strutt (SE Asia & India) was featured in TIME’s Best Inventions 2026 for its ev¹ autonomous mobility device.